Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cells.
Journal: BMC cancer
Published: October 28, 2013
Method validation of circulating tumour cell enumeration at low cell counts.
Journal: BMC cancer
Published: May 31, 2013
Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial.
Journal: British journal of cancer
Published: April 28, 2012
Application of the β-expectation tolerance interval to method validation of the M30 and M65 ELISA cell death biomarker assays.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: January 18, 2011
Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs.
Journal: British journal of cancer
Published: October 07, 2010
Fit-for-purpose biomarker method validation in anticancer drug development.
Journal: Drug discovery today
Published: March 23, 2010
Quantitative analysis of biomarkers by LC-MS/MS.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: March 21, 2009
Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity.
Journal: Molecular cancer therapeutics
Published: March 19, 2008
Biomarker method validation in anticancer drug development.
Journal: British journal of pharmacology
Published: September 19, 2007
Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma.
Journal: Cancer chemotherapy and pharmacology
Published: December 11, 2006
Glucuronidation of SN-38 and NU/ICRF 505 in human colon cancer and adjacent normal colon.
Journal: Anticancer research
Published: July 11, 2006
Last Updated: 09/26/2026